Stocks and Investing Stocks and Investing
Mon, January 11, 2021
[ 12:00 AM ] - United States, WOPRAI
Brent Thill Downgraded (SWI) to Hold and Decreased Target to $30 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Jonathan Miller Initiated (STTK) at Buy on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Michael Cyprys Downgraded (VIRT) to Sell on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Michael Cyprys Maintained (VRTS) at Hold with Increased Target to $250 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Alexander Nowak Initiated (VVOS) at Strong Buy and Held Target at $300 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Russell Gunther Downgraded (STBA) to Hold on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Peter Arment Upgraded (SPR) to Buy and Increased Target to $53 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Craig Hettenbach Maintained (ST) at Buy with Increased Target to $68 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Martin Auster Initiated (SRRK) at Buy and Held Target at $65 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Colin Bristow Downgraded (SRPT) to Hold on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Justin Jenkins Downgraded (AM) to Hold on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Jeff Kvaal Maintained (AAPL) at Sell with Increased Target to $90 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Michael Zaremski Maintained (ACGL) at Hold with Increased Target to $40 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Michael Ciarmoli Upgraded (WWD) to Hold and Held Target at $101 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Joseph Pantginis Maintained (XBIO) at Strong Buy with Increased Target to $50 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Devin McDermott Upgraded (XOM) to Buy and Increased Target to $57 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Heath Terry Initiated (UPST) at Hold and Held Target at $55 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Ronald Josey Initiated (UPST) at Hold on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Ramsey El-Assal Initiated (UPST) at Hold and Held Target at $58 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
John Hecht Initiated (UPST) at Strong Buy and Held Target at $66 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Nat Schindler Initiated (UPST) at Hold and Held Target at $57 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Brent Thill Downgraded (UPWK) to Hold and Held Target at $39 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Brian Nowak Maintained (UBER) at Buy with Increased Target to $68 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
David Vernon Upgraded (UNP) to Buy on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Fadi Chamoun Maintained (UNP) at Buy with Increased Target to $230 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
David Ross Maintained (UNP) at Hold with Increased Target to $197 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Christian Wetherbee Maintained (UNP) at Strong Bu .. with Increased Target to $250 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Kenneth Zaslow Downgraded (ANDE) to Hold and Increased Target to $26 on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Colin Sebastian Maintained (AMZN) at Buy on, Jan 11th, 2021
[ 12:00 AM ] - United States, WOPRAI
Raghuram Selvaraju Maintained (BBIO) at Strong Buy with Increased Target to $87 on, Jan 11th, 2021

Raghuram Selvaraju Maintained (BBIO) at Strong Buy with Increased Target to $87 on, Jan 11th, 2021


Published on 2024-10-27 15:10:53 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "BridgeBio Pharma, Inc." (BBIO) at Strong Buy with Increased Target from $64 to $87 on, Jan 11th, 2021.

Raghuram has made no other calls on BBIO in the last 4 months.



There is 1 other peer that has a rating on BBIO. Out of the 1 peers that are also analyzing BBIO, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram

  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Increased Target to $44 on, Friday, December 4th, 2020

Contributing Sources
    D885FD0B-4D59-419D-81DE-3DF4BF5AB503
  • support@woprai.com